Parkinson's disease is the second most common neurodegenerative disease, affecting over 10 million people worldwide. Some forms of Parkinson's disease are characterized by an inability of cells to ...

Parkinson's disease is the second most common neurodegenerative disease, affecting over 10 million people worldwide. Some forms of Parkinson's disease ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially impacting only one side of the body. Although it first manifests through motor ...

Dopamine agonists are used as an alternative to the drug L-DOPA, which can cause side effects in patients with Parkinson's, such as involuntary movements.

Stimvia announced that it completed a clinical study of its peroneal electrical transcutaneous neurmodulation (peroneal eTNM) ...

Some patients struggling with long Covid experience long-term fatigue, brain fog, breathlessness and a heavily-reduced ...

Stimvia, a medtech company based in the Czech Republic, has successfully completed a clinical study on peroneal electrical ...

A drug first developed in the 1950s for Parkinson’s disease may be an unexpected ally in the global fight against ...